Cargando…

Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles

Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dockery, Lance T., Daniel, Marie-Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459818/
https://www.ncbi.nlm.nih.gov/pubmed/37631317
http://dx.doi.org/10.3390/pharmaceutics15082103
_version_ 1785097503159353344
author Dockery, Lance T.
Daniel, Marie-Christine
author_facet Dockery, Lance T.
Daniel, Marie-Christine
author_sort Dockery, Lance T.
collection PubMed
description Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system.
format Online
Article
Text
id pubmed-10459818
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104598182023-08-27 Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles Dockery, Lance T. Daniel, Marie-Christine Pharmaceutics Article Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system. MDPI 2023-08-09 /pmc/articles/PMC10459818/ /pubmed/37631317 http://dx.doi.org/10.3390/pharmaceutics15082103 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dockery, Lance T.
Daniel, Marie-Christine
Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
title Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
title_full Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
title_fullStr Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
title_full_unstemmed Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
title_short Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
title_sort targeted doxorubicin-loaded dendronized gold nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459818/
https://www.ncbi.nlm.nih.gov/pubmed/37631317
http://dx.doi.org/10.3390/pharmaceutics15082103
work_keys_str_mv AT dockerylancet targeteddoxorubicinloadeddendronizedgoldnanoparticles
AT danielmariechristine targeteddoxorubicinloadeddendronizedgoldnanoparticles